Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remdesivir for the treatment of COVID-19
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US
Katherine A. Auger, Samir S. Shah, Troy Richardson, et al.
JAMA (2020) Vol. 324, Iss. 9, pp. 859-859
Open Access | Times Cited: 472
Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study
Ming Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1213-1224
Closed Access | Times Cited: 8
Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury
Jie Xu, Enqing Lin, Xue Hong, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 7
Harvesting phosphorus-containing moieties for their antibacterial effects
Manuela Voráčová, Matej Zore, Jari Yli‐Kauhaluoma, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117512-117512
Open Access | Times Cited: 20
Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020–2022)
Samantha Taylor, Sally J. Coggins, Emi Barker, et al.
Journal of Feline Medicine and Surgery (2023) Vol. 25, Iss. 9
Open Access | Times Cited: 15
Acteoside as a Multi-target Anti-SARS-CoV-2 Agent: An In-Silico Study
Francis O. Shode, Ayodeji Amobonye, Santhosh Pillai, et al.
Topics in Catalysis (2025)
Open Access
Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection
Bryce M. Warner, Robert Vendramelli, Amrit S. Boese, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316952-e0316952
Open Access
COVID-19 related complications
Muhamed Adilović
Progress in molecular biology and translational science (2025)
Closed Access
Nasal delivery as a strategy for the prevention and treatment of COVID-19
Fabio Sonvico, Gaia Colombo, Eride Quarta, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1115-1130
Open Access | Times Cited: 13
Antiplatelet agents for the treatment of adults with COVID-19
Anna-Lena Fischer, Sarah Messer, Rachel Riera, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 9
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances
José Luís Piñana, Ariadna Pérez, Pedro Chorão, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 8
Personalized Assessment of Mortality Risk and Hospital Stay Duration in Hospitalized Patients with COVID-19 Treated with Remdesivir: A Machine Learning Approach
Antonio Ramón, Andrés Bas, Santiago Herrero, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1837-1837
Open Access | Times Cited: 2
Assessing the Impact of Agents with Antiviral Activities on Transmembrane Ionic Currents: Exploring Possible Unintended Actions
Geng-Bai Lin, Chia‐Lung Shih, Rasa Liutkevičienė, et al.
Biophysica (2024) Vol. 4, Iss. 2, pp. 128-141
Open Access | Times Cited: 2
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis
Nicola Veronese, Francesco Di Gennaro, Luisa Frallonardo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
A community effort in SARS‐CoV‐2 drug discovery
Johannes Schimunek, Philipp Seidl, Katarina Elez, et al.
Molecular Informatics (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 Mpro
Jie Chen, Xiang Zhou, Lifeng Fu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 767-767
Open Access | Times Cited: 6
Remdesivir Treatment Lacks the Effect on Mortality Reduction in Hospitalized Adult COVID-19 Patients Who Required High-Flow Supplemental Oxygen or Invasive Mechanical Ventilation
Chienhsiu Huang, Tsung-Lung Lu, Lichen Lin
Medicina (2023) Vol. 59, Iss. 6, pp. 1027-1027
Open Access | Times Cited: 6
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
Francesco Salton, Paola Confalonieri, G. Umberto Meduri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 924-924
Open Access | Times Cited: 5
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State
Alessandro Libra, Nicola Ciancio, Gianluca Sambataro, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2101-2101
Open Access | Times Cited: 5
Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry
Marko Lucijanić, Nikolina Bušić, Petra Bistrović, et al.
Croatian Medical Journal (2022) Vol. 63, Iss. 6, pp. 536-543
Open Access | Times Cited: 9
Unlocking the Antiviral Arsenal: Multiparametric Optimization of Small-Molecule Inhibitors against RSV and hCoV-229E
Christina Karhan, Svenja M. Sake, Antonia P. Gunesch, et al.
(2024)
Open Access | Times Cited: 1
Clinical Manifestations and Outcomes of Older Patients with COVID-19: A Comprehensive Review
Jeong Eun Lee, Da Hyun Kang, Soyun Kim, et al.
Tuberculosis & respiratory diseases (2024) Vol. 87, Iss. 2, pp. 145-154
Open Access | Times Cited: 1
Personalized Assessment of Mortality Risk and Hospital Stay Duration in Hospitalized Patients with COVID-19 Treated with Remdesivir: A Machine Learning Approach
Antonio Ramón, Andrés Bas Castillo, Santiago Herrero González, et al.
(2024)
Open Access | Times Cited: 1
The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients
Moritz Platzer, David Totschnig, Mario Karolyi, et al.
Wiener klinische Wochenschrift (2024) Vol. 136, Iss. 15-16, pp. 458-464
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top